Want to join the conversation?
$EFX said that following the Veda acquisition, it started focusing on adjusted EBITDA margin to more consistently present the operating performance of the segments and the company as a whole. For 2Q16, USIS revenue was $308MM, up 3% vs. 2Q15. Revenue for Workforce Solutions was $177MM and for Global Consumer Solutions it was $107MM in 2Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?